253
Participants
Start Date
February 19, 2019
Primary Completion Date
November 1, 2025
Study Completion Date
November 1, 2028
Observational cohort
Patients will be followed by collecting clinical data, biospecimens, and quality of life assessments over a period of five years from registration.
Northern Light Cancer Care, Bangor
Brigham and Women Hospital, Boston
Dana-Farber Cancer Institute, Boston
Lifespan Cancer Institute, Providence
Susan G. Komen Breast Cancer Foundation
OTHER
Dana-Farber Cancer Institute
OTHER